283 views
Photo by Jonathan Borba from Pexels

MOH investigates telemedicine providers amidst clinical lapses, inappropriate ad complaints

One of the cases, MaNaDr, has had its Outpatient Medical Service licence revoked.

Eight telemedicine providers have been or are currently being investigated for lapses in clinical care and inappropriate advertisement complaints, according to the Ministry of Health (MOH).

Issues include doctors issuing prescriptions and medical certificates without proper clinical assessment, not conducting video consultations for first-time patients, and promoting the unnecessary use of telemedicine services.

Investigations on three of these cases were concluded and enforcement actions have been taken. One of the cases, MaNaDr, has had its Outpatient Medical Service licence revoked.

Others involve a short suspension and a stern warning, commensurate with the severity of the breaches. In addition, medical practitioners have also been referred to the Singapore Medical Council for potential lapses in professional standards.

MOH said it will take the necessary enforcement actions and advises the public to raise concerns regarding the provision of telemedicine via the public feedback channels available on its website.

Join Singapore Business Review community
Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.